BUY Sansera Engineering Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities
bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred 1 year)11 Nov 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·13 Nov · yesterday
4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days
Advisor consensus · same horizon·9 Nov · 5d ago
Sansera Engineering reported standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, showing growth in revenue and profit compared to the previous year.
BSE · Board Meeting·5 Nov · 1w ago
Sansera Engineering: QIP Funds Utilization Verified
NewsGoogle News·27 Oct · 3w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·23 Sept · 2mo ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sansera Engineering
- BUY — Chandan Taparia, Motilal Oswal11 Nov 2026 · ~2 weeks · target ₹4,850 · Active
- BUY — Axis Securities9 Nov 2026 · ~1 year · target ₹4,880 · Active
- BUY — Kush Bohra9 Nov 2026 · ~3 months · target ₹4,750 · Target hit
- BUY — Nomura India Research9 Nov 2026 · ~1 year · target ₹4,916 · Active
- BUY — Goldman Sachs9 Nov 2026 · ~1 year · target ₹5,350 · Active
More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities
- BUY Gland Pharma11 Nov 2026 · ~1 year · target ₹4,415 · Active
- BUY Alkem Laboratories9 Nov 2026 · ~2 weeks · target ₹5,730 · Active
- BUY Wockhardt9 Nov 2026 · ~2 weeks · target ₹2,480 · Active
- BUY Venus Pipes & Tubes9 Nov 2026 · ~2 weeks · target ₹2,180 · Active
- BUY ICICI Bank6 Nov 2026 · ~2 weeks · target ₹1,785 · Active

